Patents by Inventor Eti Meiri

Eti Meiri has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250027154
    Abstract: Nucleic acid molecule constructs, methods of making such construct, and methods of sequencing using such constructs are described herein. The nucleic acid molecule constructs can include a template sequence and a copy of the template sequence, along with a sequencing primer region associated with the template sequence and a copy of the sequencing primer region associated with the copy of the template sequence, which allows the template sequence and the copy of the template sequence to be simultaneously sequenced. Also described are methods of using the nucleic acid molecule constructs for methylation sequencing.
    Type: Application
    Filed: August 13, 2024
    Publication date: January 23, 2025
    Inventors: Zohar SHIPONY, Florian OBERSTRASS, Doron LIPSON, Eti MEIRI, Tommie Lloyd LINCECUM, JR., Daniel MAZUR, Omer BARAD
  • Publication number: 20240368686
    Abstract: Described herein is a composition, comprising: a first strand comprising a first portion and a first copy portion, wherein the first copy portion is a copy of the first portion except that substantially all cytosine bases in the first copy portion are methylated; and a second strand comprising a second portion and a second copy portion, wherein the second copy portion is a copy of the second portion except that substantially all cytosine bases in the second copy portion are methylated. In some implementations, at least one cytosine base in the first portion or the second portion is not methylated.
    Type: Application
    Filed: May 7, 2024
    Publication date: November 7, 2024
    Inventors: Zohar SHIPONY, Florian OBERSTRASS, Doron LIPSON, Eti MEIRI, Omer BARAD
  • Publication number: 20190300963
    Abstract: The present invention provides a method for classification of thyroid tumors through the analysis of the expression patterns of specific microRNAs in fine needle aspiration samples. Thyroid tumor classification according to a microRNA expression signature allows optimization of diagnosis and treatment, as well as determination of signature-specific therapy.
    Type: Application
    Filed: November 15, 2018
    Publication date: October 3, 2019
    Applicant: ROSETTA GENOMICS LTD.
    Inventors: Zohar Barnett-Itzhaki, Gila Lithwick Yanai, Eti Meiri, Yael Spector, Hila Benjamin, Nir Dromi
  • Publication number: 20170356055
    Abstract: The present invention provides a method for classification of thyroid tumors through the analysis of the expression patterns of specific microRNAs in fine needle aspiration samples. Thyroid tumor classification according to a microRNA expression signature allows optimization of diagnosis and treatment, as well as determination of signature-specific therapy.
    Type: Application
    Filed: June 16, 2017
    Publication date: December 14, 2017
    Inventors: Zohar Barnett-Itzhaki, Gila Lithwick Yanai, Eti Meiri, Yael Spector, Hila Benjamin, Nir Dromi
  • Patent number: 9708667
    Abstract: The present invention provides a method for classification of thyroid tumors through the analysis of the expression patterns of specific microRNAs in fine needle aspiration samples. Thyroid tumor classification according to a microRNA expression signature allows optimization of diagnosis and treatment, as well as determination of signature-specific therapy.
    Type: Grant
    Filed: August 15, 2016
    Date of Patent: July 18, 2017
    Assignee: ROSETTA GENOMICS, LTD.
    Inventors: Gila Lithwick Yanai, Eti Meiri, Yael Spector, Hila Benjamin, Nir Dromi
  • Publication number: 20170016076
    Abstract: The present invention provides a method for classification of thyroid tumors through the analysis of the expression patterns of specific microRNAs in fine needle aspiration samples. Thyroid tumor classification according to a microRNA expression signature allows optimization of diagnosis and treatment, as well as determination of signature-specific therapy.
    Type: Application
    Filed: August 15, 2016
    Publication date: January 19, 2017
    Inventors: Zohar Barnett-Itzhaki, Gila Lithwick Yanai, Eti Meiri, Yael Spector, Hila Benjamin, Nir Dromi